Insights

Innovative Diagnostic Platform Credo Diagnostics Biomedical has developed VitaPCR TM, a rapid and cost-effective molecular testing platform capable of detecting major infectious pathogens including SARS-CoV-2 within 20 minutes, positioning it as a valuable solution for healthcare providers needing quick diagnostic results.

Growing Market Presence With a revenue range between 1 and 10 million dollars and recent product launches, the company is expanding its footprint in the molecular diagnostics sector, indicating potential opportunities to collaborate with healthcare institutions seeking advanced Point-of-Care testing solutions.

Focus on Rapid Testing Credo’s emphasis on simplifying testing processes and accelerating diagnosis timelines presents a strong value proposition for clinics, hospitals, and veterinary clinics aiming to improve patient outcomes through faster diagnostics.

Technological Capabilities Leveraging a technology stack that includes PCR-based detection and rapid molecular platforms, Credo is well-positioned to provide cutting-edge diagnostic tools, providing sales opportunities to suppliers and integrators of health tech solutions.

Niche yet Competitive Operating within a niche market of rapid molecular diagnostics with close competitors that serve similar health sectors, Credo offers targeted opportunities for partners seeking innovative diagnostic solutions in infectious disease testing for both human and veterinary markets.

Similar companies to Credo Diagnostics Biomedical

Credo Diagnostics Biomedical Tech Stack

Credo Diagnostics Biomedical uses 8 technology products and services including 33Across, WordPress, Shopify, and more. Explore Credo Diagnostics Biomedical's tech stack below.

33Across
Advertising
WordPress
Content Management System
Shopify
E-commerce
Microsoft 365
Email
Font Awesome
Font Scripts
imagesLoaded
Javascript Libraries
reCAPTCHA
Security
Weglot
Translation

Media & News

Credo Diagnostics Biomedical Pte. Ltd launched VitaPCR TM on Jan 1st '19.
Founded in 2011, Credo Diagnostics launched the VitaPCR TM in 2019, a revolutionary molecular biology platform capable of detecting infectious pathogens (including the SARS-CoV-2 responsible for Covid-19, influenza and RSV viruses) by Polymerase Chain Reaction (PCR) methodology in only 20 minutes.
Jan 13, 2023 | www.marketscreener.com

Credo Diagnostics Biomedical's Email Address Formats

Credo Diagnostics Biomedical uses at least 1 format(s):

Credo Diagnostics Biomedical Email Formats	Example	Percentage
First.Last@credodxbiomed.com	John.Doe@credodxbiomed.com	42%
FMiddleLast@credodxbiomed.com	JMichaelDoe@credodxbiomed.com	8%
First.Last@credodxbiomed.com	John.Doe@credodxbiomed.com	42%
FMiddleLast@credodxbiomed.com	JMichaelDoe@credodxbiomed.com	8%

Frequently Asked Questions

Where is Credo Diagnostics Biomedical's headquarters located?

Credo Diagnostics Biomedical's main headquarters is located at 491b River Valley Road #06-01 Singapore, Central Region 248373 Singapore. The company has employees across 2 continents, including AsiaEurope.

What is Credo Diagnostics Biomedical's official website and social media links?

Credo Diagnostics Biomedical's official website is credodxbiomed.com and has social profiles on LinkedIn.

What is Credo Diagnostics Biomedical's NAICS code?

Credo Diagnostics Biomedical's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Credo Diagnostics Biomedical have currently?

As of March 2026, Credo Diagnostics Biomedical has approximately 39 employees across 2 continents, including AsiaEurope. Key team members include Chairman: W. J. W.Head, Chairman’s Office / Vice President: T. T.Vp: S. K.. Explore Credo Diagnostics Biomedical's employee directory with LeadIQ.

What industry does Credo Diagnostics Biomedical belong to?

Credo Diagnostics Biomedical operates in the Medical Equipment Manufacturing industry.

What technology does Credo Diagnostics Biomedical use?

Credo Diagnostics Biomedical's tech stack includes 33AcrossWordPressShopifyMicrosoft 365Font AwesomeimagesLoadedreCAPTCHAWeglot.

What is Credo Diagnostics Biomedical's email format?

Credo Diagnostics Biomedical's email format typically follows the pattern of First.Last@credodxbiomed.com. Find more Credo Diagnostics Biomedical email formats with LeadIQ.

When was Credo Diagnostics Biomedical founded?

Credo Diagnostics Biomedical was founded in 2011.

Credo Diagnostics Biomedical

Q: How many employees does Credo Diagnostics Biomedical have currently?

Credo Diagnostics Biomedical has approximately 39 employees.

Q: What technology does Credo Diagnostics Biomedical use?

Credo Diagnostics Biomedical's tech stack includes Yoast SEO, Shopify, jQuery, imagesLoaded, Bootstrap.

Q: What is Credo Diagnostics Biomedical's NAICS code?

Credo Diagnostics Biomedical's NAICS code is 3391 (Medical Equipment and Supplies Manufacturing).

Medical Equipment ManufacturingCentral Region, Singapore11-50 Employees

Credo Diagnostics Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases and animal health.

At Credo Diagnostics Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. 

By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world. 

For any inquiries, please contact us at: service@credodxbiomed.com

Company Overview

Headquarters: 491b River Valley Road #06-01 Singapore, Central Region 248373 Singapore
Website: credodxbiomed.com
NAICS Code: 3391 - Medical Equipment and Supplies Manufacturing
Founded: 2011
Employees: 11-50